MMR (measles, mumps and rubella) (15 mins, 2 sessions)
MMR (measles, mumps and rubella)
Price per dose: £37
Number of doses for primary course: 2
Minimum dose intervals: 4 weeks
Infants from 6 months of age travelling to measles
endemic areas or to an area where there is a current outbreak should receive
MMR (Green Book, chapter 21).
On 8 February 2019, the European Centre for Disease Prevention and
Control (ECDC) reported that measles continues to be transmitted across
Europe this year.
Young people, healthcare workers and those who are not fully
vaccinated remain at highest risk of measles.
Travel may increase an individual’s risk of exposure to
measles virus, and facilitate the spread of disease to unvaccinated and
susceptible populations.
Vaccination should be considered for:
All travellers who have not previously had two doses of a
measles containing vaccine or prior measles infection.
Particularly children and those who will be living or
working closely with the local population at their destination, in countries
with high endemnicity or recent outbreaks.
There is now overwhelming evidence that MMR does not cause
autism.
Also, it has been suggested that combined MMR vaccine could
potentially overload the immune system. From the moment of birth, humans are
exposed to countless numbers of foreign antigens and infectious agents in their
everyday environment. Responding to the three viruses in MMR would use only a
tiny proportion of the total capacity of an infant’s immune system. The three
viruses in MMR replicate at different rates from each other and would be
expected to reach high levels at different times (Green Book, chapter 21).
